Johnson & Johnson (JNJ) Receivables (2009 - 2026)

Johnson & Johnson has disclosed Receivables across 18 years of filings, most recently posting $17.7 billion for Q1 2026.

• Receivables for Q1 2026 came in at $17.7 billion, up 10.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.7 billion (up 10.62% YoY), and the FY2025 annual result was $17.2 billion, up 15.74% from the prior year.
• Receivables came in at $17.7 billion for Q1 2026 at Johnson & Johnson, up from $17.2 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $17.8 billion in Q2 2025 to a low of $14.0 billion in Q1 2023.
• The 5-year median for Receivables is $16.0 billion (2022), against an average of $16.0 billion.
• Across the five-year window, Receivables retreated 8.59% in 2024 and advanced 15.74% in 2025, its largest moves.
• Johnson & Johnson's Receivables stood at $15.9 billion in 2022, then decreased by 6.4% to $14.9 billion in 2023, then fell by 0.21% to $14.8 billion in 2024, then grew by 15.74% to $17.2 billion in 2025, then gained by 3.16% to $17.7 billion in 2026.
• The last three Receivables figures came in at $17.7 billion (Q1 2026), $17.2 billion (Q4 2025), and $17.6 billion (Q3 2025), per Business Quant data.